Treatment Registry
TR-0603 ActiveRecorded September 2026

Compounded tirzepatide

Sold by Mevo Health · every compounded tirzepatide record

The register has not established whether this program ships a vial, a pen, or another form. That is a gap in our record, not a statement about the company.

Recorded initial charges

First month

$259

first month, including required fees on record. The published monthly rate excludes one-time and annual fees; introductory and conditional rates may change. Some fee details are unverified or unpublished; this sum does not establish the full amount payable.

Medication · Starting price · recorded initial monthly payment$259

Added from the figures recorded below.

Price

TermPer monthCharged today
Starting price

“Compounded Tirzepatide Injections GLP-1 / GIP Dual Hormone Therapy As low as $ 259”

Per month$259Charged today$259
Price sources
Visit Mevo Health

We earn nothing from this link. It opens Mevo Health's website without a paid referral.

History

Fewer than two comparable calendar-month readings are available for a price trend. Day- or week-based supplies, introductory offers and unverified payment terms are not connected in this chart.

  • September 2026 — Entry added to the register

Sourcing and terms

PrescriberAsynchronous review
CancellationCertain Mevo Health programs, such as hormone health or weight management, may include additional terms and fees, which will be presented prior to enrollment. You may cancel or delay participation at any time by emailing care@mevohealth.com .

Not yet checked: pharmacy, states, membership and consult fee.

Recorded from mevohealth.com. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.

Notes

  1. 1. September 2026 — Homepage also states plans are offered 'in monthly, quarterly, and six-month options' but no separate dollar figures for the longer terms are given anywhere in the crawled pages. No explicit named-state list or 'all 50 states' claim was found; the terms page only says service is available in 'specific states' without naming them.

Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.

This record

Entry
TR-0603
Medication category
compounded tirzepatide
Readings
1

Related records

Other records from Mevo Health

All Mevo Health programs and terms

Compounded tirzepatide at a similar price

The records either side of this one in the recorded spread. Not a ranking, and not a recommendation — a position among 374 records of the same molecule.

Cite this entry

Treatment Registry. (2026). Mevo Health — compounded tirzepatide (TR-0603). Last verified September 2026. Retrieved [your access date], from https://treatmentregistry.com/registry/TR-0603

Replace the bracket with the date you read it. Ours is the date we last checked the figures, which is a different thing and is given separately.